Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · IEX Real-Time Price · USD
1.040
+0.010 (0.97%)
At close: May 17, 2024, 4:00 PM
1.010
-0.030 (-2.88%)
After-hours: May 17, 2024, 7:49 PM EDT
Unicycive Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for UNCY stock have an average target of 5.50, with a low estimate of 3.00 and a high estimate of 9.00. The average target predicts an increase of 428.85% from the current stock price of 1.04.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for UNCY stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
Buy | 1 | 1 | 2 | 2 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 5 | 4 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4.5 | Strong Buy | Reiterates | $4.5 | +332.69% | May 14, 2024 |
Benchmark | Benchmark | Buy Reiterates $3 | Buy | Reiterates | $3 | +188.46% | Apr 15, 2024 |
Piper Sandler | Piper Sandler | Buy Initiates $9 | Buy | Initiates | $9 | +765.38% | Apr 4, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4.5 | Strong Buy | Reiterates | $4.5 | +332.69% | Apr 1, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4.5 | Strong Buy | Reiterates | $4.5 | +332.69% | Mar 14, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
3.14M
EPS This Year
-0.71
from -1.28
EPS Next Year
-0.70
from -0.71
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | 4.3M | 522.5M | 1.2B | 461.3M |
Avg | n/a | 3.1M | 263.9M | 432.9M | 272.7M |
Low | n/a | 2.0M | 19.3M | 37.5M | 60.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 16,535.8% | 352.9% | 6.6% |
Avg | - | - | 8,300.2% | 64.1% | -37.0% |
Low | - | - | 515.0% | -85.8% | -86.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.64 | -0.46 | 5.05 | 10.74 | 2.93 |
Avg | -0.71 | -0.70 | 2.14 | 3.44 | 1.26 |
Low | -0.77 | -0.91 | -0.61 | -0.31 | 0.31 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 402.7% | -14.9% |
Avg | - | - | - | 61.0% | -63.3% |
Low | - | - | - | - | -90.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.